SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication February 19, 2018 4 Clinical Projects Shelved From Pfizer???s Pipeline August 1, 2017 GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017
GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017
